White label ELPA - ClinicalTrials.eu

Study of Darbepoetin Alfa to Reduce Blood Transfusion Needs During Liver Transplant Surgery

Recruiting

3 1 1 1
Investigated Drugs:
- Darbepoetin Alfa
Study of lavender oil (Silexan) in patients with mild to moderate major depressive disorder comparing its effectiveness to placebo

Recruiting

3 1
Investigated Diseases:
- Major depression
Investigated Drugs:
- Lavender Oil
Study of RVU120 treatment in patients with myelodysplastic syndrome, solid tumors, or acute myeloid leukemia who benefited from previous RVU120 therapy

Recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
Study of brimonidine tartrate gel to prevent nerve damage in breast cancer patients receiving taxane treatment

Recruiting

2 1 1
Investigated Diseases:
- Neuropathy peripheral
Investigated Drugs:
- Brimonidine Tartrate
Study comparing diclofenac, orphenadrine and paracetamol combination versus diclofenac alone and orphenadrine-paracetamol combination in patients with acute low back pain

Recruiting

3 1 1
Investigated Drugs:
- DICLOFENAC POTASSIUM
- Paracetamol
Study comparing GSK5764227 and topotecan in adults with relapsed small cell lung cancer

Recruiting

3 1 1 1
Investigated Drugs:
- GSK5764227
- Topotecan
+7
Study of PRAX-628 to evaluate safety and effectiveness in adults with epilepsy who have focal seizures or generalized tonic-clonic seizures

Recruiting

3 1 1
Investigated Drugs:
- VORMATRIGINE
- Prax-628
Comparing Ropivacaine with Epinephrine Injection Methods for Pain and Bleeding Control in Patients Undergoing Lumbar Fusion Surgery

Recruiting

3 1 1 1
Investigated Drugs:
- Epinephrine
- Ropivacaine Hydrochloride
Early detection of heart damage using cardiac magnetic resonance imaging in cancer patients receiving doxorubicin, epirubicin, pixantrone and other anthracyclines

Recruiting

3 1 1 1
Investigated Diseases:
- Chemotherapy cardiotoxicity attenuation
Investigated Drugs:
Study of LUMC-BOB1-B7-TCR.

Recruiting

2 1 1
Investigated Diseases:
Investigated Drugs:
- LUMC-BOB1-B7-TCR.1

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies